EW — Edwards Lifesciences Corporation
Healthcare · ETF XLV · as of 2026-09-23
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. The company offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband brands. I...
Price & today
| Stock today | -2.21% |
| Sector ETF today | -0.64% |
| Residual (stock-specific) | -1.57% |
Sector correlation
| 20-day correlation with XLV | 0.48 |
| 60-day correlation with XLV | 0.39 |
| Status | normal |
Decoupling fires when 60d corr − 20d corr > 0.20: stock used to track its sector but the relationship has weakened recently.
Technicals
| 10 EMA | $87.81 |
| 20 EMA | $88.22 |
| 50 EMA | $88.43 |
| EMA stack | BEARISH |
| RSI(14) | 43.8 |
| 52-week high distance | -9.83% |
| 52-week low distance | +20.08% |
Signals
| Market F&G | 44.9 |
| Bull% | 13.8% |
| OVTLYR status | SELL (16d) |
| Sector rank | #283 |
| Next earnings | 2026-10-28 (AMC, 34d) |
MarketSmith metrics - our compute
What do these abbreviations mean?
- RS Rating
- - IBD-style relative strength vs SPY (weighted 3/6/9/12-mo). 70+ = leaders pool, 80+ = strong.
- ADR%
- - average daily range over 20 days. 4%+ = the fast movers the playbook prefers (selection order, not a gate).
- RMV (tight)
- - Relative Measured Volatility, 15 bars, scaled 0-100. <15 = tight coiled base (green), <35 moderate, high = loose/expanding - not a base right now.
- Ext (ATR>20EMA)
- - how many ATRs price sits above its 20-EMA. ≤1 = in value (green), >2 = extended/chasing (red) - prefer a pullback.
- Rel Vol
- - latest volume vs the 50-day average. 100% = normal; 140%+ = breakout confirmation.
- U/D 50d / 25d
- - up-day vs down-day volume over the window. 1.1+ = net accumulation (institutions buying); under 0.9 on the 25d = net selling.
- Accum/Dist 25d
- - heavy-volume up days vs heavy-volume down days in the last 25 sessions (close moved 0.2%+ on above-average volume). The institutional-participation footprint; 5+ distribution days = O'Neil caution line.
- LoD dist
- - close distance above the day low in % of ATR (100 = one full ATR off the low). High = strong close.
- Off/Above 52w
- - trend-template legs: within 25% of the 52-week high, at least 25% above the 52-week low.
- Trend 8/8
- - all 8 Minervini Trend Template criteria pass. Discovery floor, NOT an entry signal - entries come from the VCP pivot.
- Base len (VCP)
- - weeks since the VCP base started on the latest scan. 10wk+ bases carry the edge; short stacked bases test below random.
Fundamentals & valuation - reference, not entry inputs
Company data - context read, not entry inputs
Quarterly EPS - earnings acceleration
A dash in %Chg is deliberate: the year-ago figure was a loss, so a growth % would be meaningless. A dash in Sales means we have no revenue figure for that quarter - read it as a gap in our data, not as zero revenue.
| Quarter | EPS ($) | %Chg YoY | Sales ($M) | %Chg |
|---|---|---|---|---|
| Oct-24 | 0.67 | +14% | 1,354.4 | +9% |
| Feb-25 | 0.59 | -8% | 1,385.8 | +9% |
| Apr-25 | 0.64 | -3% | 1,412.7 | +6% |
| Jul-25 | 0.67 | -4% | 1,532.2 | +12% |
| Oct-25 | 0.67 | +0% | 1,553.1 | +15% |
| Feb-26 | 0.58 | -2% | 1,569.6 | +13% |
| Apr-26 | 0.78 | +22% | 1,648.6 | +17% |
| Jul-26 | 0.78 | +16% | 1,741.0 | +14% |
eps_actual (the figure MarketSmith/Deepvue show) - whether a given quarter is GAAP or excludes a one-off follows the filing, so it can sit either side of another vendor's number; AAPL's Oct-24 row, the Sep-2024 fiscal quarter, is $0.97 here - GAAP, including the EU tax charge - where TradingView's year implies $1.64 · Sales ($M) = SEC EDGAR quarterly revenue (fiscal Q4 derived as FY minus 9-mo) · quarter = report month · %Chg blank = prior-year base under $0.05 (not meaningful).Recent news - our DB (Finnhub + OVTLYR)
- Sep 02 · Edwards Lifesciences to Present at the Deutsche Bank Healthcare Summit Yahoo
- Sep 01 · Why Is ISRG Investing More Aggressively in R&D Despite Macro Headwinds? Yahoo
- Sep 01 + Why Is ISRG Investing More Aggressively in R&D Despite Macro Headwinds? Zacks Investment Research
- Aug 31 · Unusual Volume in Edwards Lifesciences Put Options Shows Investors Bullish on EW Stock Yahoo
- Aug 28 · Edwards Lifesciences (EW): The Medical Device Leader Behind the TAVR Boom Yahoo
- Aug 27 · Why Is IQVIA (IQV) Up 5.6% Since Last Earnings Report? Yahoo
- Aug 27 · Insider Move: Daveen Chopra Exercises Options, Realizing $551K At Edwards Lifesciences Benzinga
- Aug 26 · MDT's Q1 Earnings on Deck: How Should You Play the Stock Now? Yahoo